Skip to content

BAXALTA BELGIUM MANUFACTURING

Active
Public limited companyfounded 201411 yrs activeBoulevard René Branquart(L) 80, 7860 Lessines, BelgiumKBO/BCE: BE 0563.700.454
Summary

BAXALTA BELGIUM MANUFACTURING has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €533.78M and a net result of €27.07M. Equity is growing by ~16.6% per year across the filed fiscal years. Its solvency ranks better than 80% of 65 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
59 / 100
Fair
A confirmed filing finding caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability79=
Solvency100=
Growth51▲+1
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2M at 30 days only on tighter terms
Liquidity tight (current ratio 1.07 against 1.29 in 2024; short-term debt: 20.5% and cash: 0% of total assets), and 20.5% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
79.5%
Return on assets
4%
Age of the figures
18 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 21
Relative position
BE, all sectors
reference
Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
about 14% more bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 11 years 0 20 y
raises risk · Filed more than 90 days late
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 10-09-2026, 314 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 10 filings
Deviation from the deadline
2025
314 d late
2024
2 d early
2023
27 d early
2022
9 d late
2021
46 d late
2020
4 d late
2018
48 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven months
Position in the running window
31-03-2026 close25-09-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€345.05M▲ 6.7%
2024 · €323.24M
2020: €278.11M 2021: €255.44M▼ -8.2% vs 2020lowest in 6 years 2022: €274.83M▲ +7.6% vs 2021 2023: €299.97M▲ +9.2% vs 2022 2024: €323.24M▲ +7.8% vs 2023 2025: €345.05M▲ +6.7% vs 2024highest in 6 years
2020 → 2025
EBIT margin
10.2%▲ 1.2pp
2024 · 9.0%
2020: 9.6% 2021: 10.3%▲ +6.8% vs 2020highest in 6 years 2022: 9.3%▼ -9.3% vs 2021 2023: 9.3%▼ -0.6% vs 2022 2024: 9.0%▼ -2.8% vs 2023lowest in 6 years 2025: 10.2%▲ +13.4% vs 2024
2020 → 2025
Net result
€27.07M▲ 13.4%
2024 · €23.88M
2020: €27.77Mhighest in 6 years 2021: €22.45M▼ -19.2% vs 2020 2022: €19.23M▼ -14.3% vs 2021lowest in 6 years 2023: €21.50M▲ +11.8% vs 2022 2024: €23.88M▲ +11.1% vs 2023 2025: €27.07M▲ +13.4% vs 2024
2020 → 2025
Working capital
€10.02M▼ 72.2%
2024 · €36.08M
2020: €-117.93Mlowest in 6 years 2021: €26.50M▲ +122% vs 2020 2022: €137.63M▲ +419% vs 2021highest in 6 years 2023: €119.44M▼ -13.2% vs 2022 2024: €36.08M▼ -69.8% vs 2023 2025: €10.02M▼ -72.2% vs 2024
2020 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€255.44M-€274.83M▲ 7.6%€299.97M▲ 9.2%€323.24M▲ 7.8%€345.05M▲ 6.7% 2021: €255.44Mlowest in 5 years 2022: €274.83M▲ +7.6% vs 2021 2023: €299.97M▲ +9.2% vs 2022 2024: €323.24M▲ +7.8% vs 2023 2025: €345.05M▲ +6.7% vs 2024highest in 5 years
Equity€295.53M-€413.77M▲ 40.0%€434.38M▲ 5.0%€457.78M▲ 5.4%€533.78M▲ 16.6% 2021: €295.53Mlowest in 5 years 2022: €413.77M▲ +40.0% vs 2021 2023: €434.38M▲ +5.0% vs 2022 2024: €457.78M▲ +5.4% vs 2023 2025: €533.78M▲ +16.6% vs 2024highest in 5 years
Operating result€26.26M-€25.62M▼ 2.4%€27.79M▲ 8.5%€29.10M▲ 4.7%€35.22M▲ 21.1% 2021: €26.26M 2022: €25.62M▼ -2.4% vs 2021lowest in 5 years 2023: €27.79M▲ +8.5% vs 2022 2024: €29.10M▲ +4.7% vs 2023 2025: €35.22M▲ +21.1% vs 2024highest in 5 years
Net result€22.45M-€19.23M▼ 14.3%€21.50M▲ 11.8%€23.88M▲ 11.1%€27.07M▲ 13.4% 2021: €22.45M 2022: €19.23M▼ -14.3% vs 2021lowest in 5 years 2023: €21.50M▲ +11.8% vs 2022 2024: €23.88M▲ +11.1% vs 2023 2025: €27.07M▲ +13.4% vs 2024highest in 5 years
Result per fiscal year
Operating resultNet result
€0€10.00M€20.00M€30.00M€40.00MOperating result 2021: €26.26M€26.26MNet result 2021: €22.45M€22.45MOperating result 2022: €25.62M€25.62MNet result 2022: €19.23M€19.23MOperating result 2023: €27.79M€27.79MNet result 2023: €21.50M€21.50MOperating result 2024: €29.10M€29.10MNet result 2024: €23.88M€23.88MOperating result 2025: €35.22M€35.22MNet result 2025: €27.07M€27.07M20212022202320242025€0€10M€20M€30M€40MOperating result 2023: €27.79M€28MNet result 2023: €21.50M€21MOperating result 2024: €29.10M€29MNet result 2024: €23.88M€24MOperating result 2025: €35.22M€35MNet result 2025: €27.07M€27M202320242025
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 21% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €671.26M
Fixed assets €523.86M ▲ 24.2%
Current assets €147.40M ▼ 8.6%
Equity and liabilities €671.26M
Equity €533.78M ▲ 16.6%
Provisions €100k ▼ 5.2%
Debt €137.38M ▲ 9.7%
Debt's share of the balance-sheet total falls from 21.5% to 20.5%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€60.51M▲
2024 · €55.02M
Cash flow
€52.35M▲
2024 · €49.80M
Current ratio
1.07▼
2024 · 1.29
Quick ratio
0.34▼
2024 · 0.58
Debt to equity
0.26▼
2024 · 0.27
ROE
5.1%▼
2024 · 5.2%
ROA
4.0%▼
2024 · 4.1%
Interest coverage
81.16▼
2024 · 1182.12
Debt ≤ 1 year
€137.38M▲
2024 · €125.26M
Income taxes
€11.18M▲
2024 · €8.86M
Staff costs
€118.04M▲
2024 · €116.22M
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 79 lines
Balance sheet Code20242025
Assets
Total assets20/58€583.14M€671.26M▲
Fixed assets21/28€421.80M€523.86M▲
Intangible fixed assets21€2.55M€2.49M▼
Tangible fixed assets22/27€419.25M€521.36M▲
Land and buildings22€86.37M€87.62M▲
Plant, machinery and equipment23€167.43M€167.54M▲
Furniture and vehicles24€5.34M€6.67M▲
Assets under construction and advance payments27€160.11M€259.54M▲
Current assets29/58€161.34M€147.40M▼
Stocks and contracts in progress3€88.15M€100.48M▲
Stocks30/36€88.15M€100.48M▲
Raw materials and consumables30/31€84.71M€95.47M▲
Work in progress32€3.44M€5.01M▲
Amounts receivable within one year40/41€71.09M€43.84M▼
Trade receivables40€60.27M€33.98M▼
Other amounts receivable41€10.83M€9.86M▼
Cash at bank and in hand54/58€183k€293k▲
Deferred charges and accrued income490/1€1.91M€2.78M▲
Equity and liabilities
Total equity and liabilities10/49€583.14M€671.26M▲
Equity10/15€457.78M€533.78M▲
Contributions10/11€250.68M€300.68M▲
Capital10€201.66M€201.66M=
Issued capital100€201.66M€201.66M=
Outside capital11€49.02M€99.02M▲
Share premium1100/10€49.02M€99.02M▲
Reserves13€5.96M€7.32M▲
Non-distributable reserves130/1€5.96M€7.32M▲
Legal reserve130€5.92M€7.27M▲
Other1319€44k€44k=
Profit (loss) carried forward14€191.63M€217.35M▲
Investment grants15€9.50M€8.43M▼
Provisions and deferred taxes16€105k€100k▼
Deferred taxes168€105k€100k▼
Amounts payable17/49€125.26M€137.38M▲
Amounts payable within one year42/48€125.26M€137.38M▲
Financial debts43€1.95M€19.57M▲
Other loans439€1.95M€19.57M▲
Trade debts44€89.96M€79.75M▼
Suppliers440/4€89.96M€79.75M▼
Taxes, remuneration and social security45€33.28M€38.01M▲
Taxes450/3€1.62M€3.36M▲
Remuneration and social security454/9€31.66M€34.66M▲
Other amounts payable47/48€63k€41k▼
Income statement Code20242025
Operating income70/76A€338.49M€362.80M▲
Turnover70€323.24M€345.05M▲
Change in stocks of work in progress, finished goods and contracts in progress71€-1.51M€1.57M▲
Own construction capitalised72€9.43M€8.43M▼
Other operating income74€7.14M€7.75M▲
Non-recurring operating income76A€185k-
Operating charges60/66A€309.39M€327.58M▲
Goods for resale, raw materials and consumables60€87.80M€95.87M▲
Purchases600/8€98.83M€110.10M▲
Change in stocks: decrease (increase)609€-11.03M€-14.23M▼
Services and other goods61€76.93M€83.69M▲
Remuneration, social security and pensions62€116.22M€118.04M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€25.92M€25.28M▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€1.83M€3.47M▲
Other operating charges640/8€687k€685k▼
Non-recurring operating charges66A€0€539k▲
Operating profit (loss)9901€29.10M€35.22M▲
Financial income75/76B€3.91M€4.49M▲
Recurring financial income75€3.91M€4.49M▲
Income from current assets751€2.83M€3.39M▲
Other financial income752/9€1.08M€1.10M▲
Financial charges65/66B€276k€1.47M▲
Recurring financial charges65€276k€1.47M▲
Debt charges650€47k€746k▲
Other financial charges652/9€229k€724k▲
Profit (loss) for the period before taxes9903€32.73M€38.24M▲
Transfer from deferred taxes780€6k€5k▼
Income taxes67/77€8.86M€11.18M▲
Taxes670/3€8.86M€11.18M▲
Profit (loss) for the period9904€23.88M€27.07M▲
Profit (loss) for the period to be appropriated9905€23.88M€27.07M▲
Appropriation of the result
Profit (loss) to be appropriated9906€192.83M€218.70M▲
Profit (loss) brought forward from the previous period14P€168.95M€191.63M▲
Transfer to equity691/2€1.19M€1.35M▲
To the legal reserve6920€1.19M€1.35M▲
Social balance
Average headcount (FTE)90871,189.01,187.7▼

The notes to these accounts (69 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Operating income70/76A-€287.10M€314.25M€338.49M€362.80M▲ 7.2%
Turnover70€255.44M€274.83M€299.97M€323.24M€345.05M▲ 6.7%
Change in stocks of work in progress, finished goods and contracts in progress71-€-409k€1.29M€-1.51M€1.57M▲ 204%
Own construction capitalised72-€7.77M€7.26M€9.43M€8.43M▼ 10.6%
Other operating income74-€4.91M€5.73M€7.14M€7.75M▲ 8.6%
Non-recurring operating income76A---€185k--
Operating charges60/66A-€261.48M€286.46M€309.39M€327.58M▲ 5.9%
Goods for resale, raw materials and consumables60-€79.27M€81.05M€87.80M€95.87M▲ 9.2%
Purchases600/8-€94.62M€96.44M€98.83M€110.10M▲ 11.4%
Change in stocks: decrease (increase)609-€-15.35M€-15.39M€-11.03M€-14.23M▼ 29.0%
Services and other goods61-€56.19M€66.88M€76.93M€83.69M▲ 8.8%
Remuneration, social security and pensions62-€99.89M€110.86M€116.22M€118.04M▲ 1.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18.33M€25.17M€24.93M€25.92M€25.28M▼ 2.5%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€-175k€443k€1.83M€3.47M▲ 89.5%
Other operating charges640/8-€713k€668k€687k€685k▼ 0.4%
Non-recurring operating charges66A-€425k€1.64M€0€539k-
Operating profit (loss)9901€26.26M€25.62M€27.79M€29.10M€35.22M▲ 21.1%
Financial income75/76B-€1.45M€2.13M€3.91M€4.49M▲ 14.7%
Recurring financial income75€839k€1.45M€2.13M€3.91M€4.49M▲ 14.7%
Income from current assets751-€2k€1.10M€2.83M€3.39M▲ 19.9%
Other financial income752/9-€1.45M€1.03M€1.08M€1.10M▲ 1.3%
Financial charges65/66B-€555k€460k€276k€1.47M▲ 433%
Recurring financial charges65€927k€555k€460k€276k€1.47M▲ 433%
Debt charges650€241k€79k€49k€47k€746k▲ 1,502%
Other financial charges652/9-€476k€410k€229k€724k▲ 216%
Profit (loss) for the period before taxes9903€27.95M€26.52M€29.46M€32.73M€38.24M▲ 16.8%
Transfer from deferred taxes780-€6k€6k€6k€5k▼ 8.2%
Income taxes67/77€5.51M€7.29M€7.97M€8.86M€11.18M▲ 26.1%
Taxes670/3-€7.29M€7.97M€8.86M€11.18M▲ 26.1%
Profit (loss) for the period9904€22.45M€19.23M€21.50M€23.88M€27.07M▲ 13.4%
Profit (loss) for the period to be appropriated9905€22.45M€19.23M€21.50M€23.88M€27.07M▲ 13.4%
Line20212022202320242025Change
Assets
Total assets20/58€378.38M€497.84M€521.57M€583.14M€671.26M▲ 15.1%
Fixed assets21/28€269.36M€276.26M€315.04M€421.80M€523.86M▲ 24.2%
Intangible fixed assets21€1.34M€1.29M€2.32M€2.55M€2.49M▼ 2.3%
Tangible fixed assets22/27€268.01M€274.97M€312.73M€419.25M€521.36M▲ 24.4%
Land and buildings22-€69.79M€70.65M€86.37M€87.62M▲ 1.4%
Plant, machinery and equipment23-€152.07M€152.79M€167.43M€167.54M▲ 0.1%
Furniture and vehicles24-€2.58M€2.81M€5.34M€6.67M▲ 24.7%
Assets under construction and advance payments27-€50.53M€86.48M€160.11M€259.54M▲ 62.1%
Current assets29/58€109.02M€221.59M€206.52M€161.34M€147.40M▼ 8.6%
Stocks and contracts in progress3€49.11M€64.23M€80.46M€88.15M€100.48M▲ 14.0%
Stocks30/36-€64.23M€80.46M€88.15M€100.48M▲ 14.0%
Raw materials and consumables30/31-€60.56M€75.51M€84.71M€95.47M▲ 12.7%
Work in progress32-€3.66M€4.95M€3.44M€5.01M▲ 45.6%
Amounts receivable within one year40/41€53.96M€156.69M€124.26M€71.09M€43.84M▼ 38.3%
Trade receivables40-€50.52M€57.25M€60.27M€33.98M▼ 43.6%
Other amounts receivable41-€106.17M€67.02M€10.83M€9.86M▼ 8.9%
Cash at bank and in hand54/58€4.99M€4k€87k€183k€293k▲ 59.9%
Deferred charges and accrued income490/1-€663k€1.71M€1.91M€2.78M▲ 45.8%
Equity and liabilities
Total equity and liabilities10/49€378.38M€497.84M€521.57M€583.14M€671.26M▲ 15.1%
Equity10/15€295.53M€413.77M€434.38M€457.78M€533.78M▲ 16.6%
Contributions10/11€150.68M€250.68M€250.68M€250.68M€300.68M▲ 19.9%
Capital10-€201.66M€201.66M€201.66M€201.66M=
Issued capital100-€201.66M€201.66M€201.66M€201.66M=
Outside capital11-€49.02M€49.02M€49.02M€99.02M▲ 102%
Share premium1100/10-€49.02M€49.02M€49.02M€99.02M▲ 102%
Reserves13€2.73M€3.70M€4.77M€5.96M€7.32M▲ 22.7%
Non-distributable reserves130/1-€3.70M€4.77M€5.96M€7.32M▲ 22.7%
Legal reserve130-€3.65M€4.73M€5.92M€7.27M▲ 22.9%
Other1319-€44k€44k€44k€44k=
Profit (loss) carried forward14€130.26M€148.53M€168.95M€191.63M€217.35M▲ 13.4%
Investment grants15-€10.86M€9.98M€9.50M€8.43M▼ 11.3%
Provisions and deferred taxes16€123k€117k€111k€105k€100k▼ 5.2%
Deferred taxes168-€117k€111k€105k€100k▼ 5.2%
Amounts payable17/49€82.72M€83.96M€87.08M€125.26M€137.38M▲ 9.7%
Amounts payable after more than one year17€200k-----
Amounts payable within one year42/48€82.52M€83.96M€87.08M€125.26M€137.38M▲ 9.7%
Current portion of amounts payable after more than one year42-€141k€0---
Financial debts43-€17.44M€0€1.95M€19.57M▲ 905%
Other loans439-€17.44M€0€1.95M€19.57M▲ 905%
Trade debts44€32.13M€40.96M€56.99M€89.96M€79.75M▼ 11.4%
Suppliers440/4-€40.96M€56.99M€89.96M€79.75M▼ 11.4%
Taxes, remuneration and social security45-€25.39M€30.06M€33.28M€38.01M▲ 14.2%
Taxes450/3-€2.29M€1.13M€1.62M€3.36M▲ 107%
Remuneration and social security454/9-€23.10M€28.93M€31.66M€34.66M▲ 9.5%
Other amounts payable47/48-€24k€26k€63k€41k▼ 35.7%
Line20212022202320242025Change
Profit (loss) for the period9904€22.45M€19.23M€21.50M€23.88M€27.07M▲ 13.4%
+ Depreciation and write-downs630€18.33M€25.17M€24.93M€25.92M€25.28M▼ 2.5%
Operating cash flow (approximation)€40.77M€44.40M€46.42M€49.80M€52.35M▲ 5.1%
Investment in fixed assets (approximation)-€-32.07M€-63.71M€-132.68M€-127.34M▲ 4.0%
Change in cash-€-4.99M€82k€96k€110k▲ 13.8%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-10-2026
2026
10-09
NBB filing Annual accounts filed
fiscal year 2025 · full schema · 314 days late
16-07
State Gazette act Capital & shares · Statutes amendment
Capital increase · Capital · Powers grant5 facts ▸
  • General meeting, 26-06-2026
  • Capital increase, €130.000.000
  • Capital, €331.661.166,1
  • Statutes amendment
  • Powers grant, Pouvoirs à l'organe d'administration
13-03
State Gazette act Resignation: Patricia DENEGRI (director)
6 facts ▸
  • General meeting, 19-02-2026
  • Director resignation, Patricia DENEGRI (director)
  • Board composition, François HUPET (director)
  • Board composition, Indrajana MOELJADI (director)
  • Board composition, Valerie DE SCHUTTER (director)
  • Board composition, Thierry PESTIAUX (director)
06-01
State Gazette act Resignations & appointments
Power of attorney3 facts ▸
  • Board meeting, 21-11-2025
  • Power of attorney, Geoffrey POT
  • Power of attorney, Thierry PESTIAUX
2025
24-11
State Gazette act Reappointment: KPMG Réviseurs d'Entreprises SRL (statutory auditor)
Permanent representative: Axel JORION3 facts ▸
  • General meeting, 30-09-2025
  • Auditor reappointment, KPMG Réviseurs d'Entreprises SRL
  • Permanent representative, Axel JORION
18-11
State Gazette act Resignation: Geoffrey POT (director)
Appointment: Thierry PESTIAUX (director) · Mandate compensation9 facts ▸
  • General meeting, 22-10-2025
  • Director resignation, Geoffrey POT (director)
  • Director appointment, Thierry PESTIAUX (director)
  • Mandate compensation, Thierry PESTIAUX
  • Board composition, François HUPET (director)
  • Board composition, Indrajana MOELJADI (director)
  • Board composition, Patricia DENEGRI (director)
  • Board composition, Valerie DE SCHUTTER (director)
  • Board composition, Thierry PESTIAUX (director)
31-03
Financial Equity above €500MEq €533.78M ▲16.6%
6 profitable years in a row build equity to €533.78M.
2024
19-12
State Gazette act Capital & shares
Capital increase · Share issue · Bank account7 facts ▸
  • General meeting, 10-12-2024
  • Capital increase, €23,36
  • Share issue, action de même nature, 1
  • Bank account, 04-12-2024
  • Reserve release, 49.999.976,64 EUR, disponible
  • Capital, €201.661.166,1
  • Statutes amendment
29-10
NBB filing Annual accounts filed
fiscal year 2024 · full schema
13-05
State Gazette act Resignations & appointments
Power of attorney9 facts ▸
  • Board meeting, 12-03-2024
  • Power of attorney, Anna Szulc
  • Power of attorney, Katarzyna Charusta-Gapinska
  • Power of attorney, Joanna Garbacz
  • Power of attorney, Adrian Kaczorowski
  • Power of attorney, Marta Lirka
  • Power of attorney, Alicja Minich
  • Power of attorney, Sylvie Murez
  • Power of attorney, Pascal Lepelletier
2023
04-10
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2022
23-11
State Gazette act Reappointments: Valérie De Schutter, François Hupet and KPMG Réviseurs d'Entreprises SRL
Mandate compensation6 facts ▸
  • General meeting, 21-10-2022
  • Director reappointment, Valérie De Schutter (director)
  • Director reappointment, François Hupet (director)
  • Mandate compensation, Valérie De Schutter
  • Mandate compensation, François Hupet
  • Auditor reappointment, KPMG Réviseurs d'Entreprises SRL (statutory auditor)
Show earlier events
09-11
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 9 days late
08-11
State Gazette act Resignations & appointments
Power of attorney5 facts ▸
  • Board meeting, 12-10-2021
  • Power of attorney, Sylvie Murez
  • Power of attorney, Daniela Paoloni
  • Power of attorney, Catherine Sonveaux
  • Power of attorney, Nathalie Van Eetveldt
31-03
Financial Weakest financial yearnet €19.23M ▼14.3%
Net result drops to €19.23M, the lowest in the series; recovery starts the following year.
28-03
State Gazette act Capital & shares
Capital increase · Bank account · Capital5 facts ▸
  • General meeting, 21-03-2022
  • Capital increase, €50.984.789,74
  • Bank account, Deutsche Bank
  • Capital, €201.661.142,74
  • Share participation, from the start of the fiscal year beginning 1 April 2021
2021
16-12
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 46 days late
26-11
State Gazette act Resignations: Ramon Sanchez Carbajal (director) and Pierre Dorignaux (director)
Appointments: Patricia Denegri (director) and Indrajana Moeljadi (director) · Mandate compensation · Power of attorney9 facts ▸
  • General meeting, 07-10-2021
  • Director resignation, Ramon Sanchez Carbajal (director)
  • Director resignation, Pierre Dorignaux (director)
  • Director appointment, Patricia Denegri (director)
  • Director appointment, Indrajana Moeljadi (director)
  • Mandate compensation, Patricia Denegri
  • Mandate compensation, Indrajana Moeljadi
  • Board meeting, 12-10-2021
  • Power of attorney, Patricia Denegri
31-03
Financial Liquidity triplescurrent ratio 1.32
Current ratio from 0.49 to 1.32; short-term debt falls from €231.68M to €82.52M.
31-03
Financial Equity above €250MEq €295.53M ▲113%
2 profitable years in a row build equity to €295.53M.
18-02
State Gazette act Miscellaneous
Power of attorney3 facts ▸
  • Board meeting, 21-01-2021
  • Power of attorney, Yves Legrand
  • Power of attorney, Geoffrey Pot (mandataire)
2020
15-12
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Capital4 facts ▸
  • General meeting, 03-12-2020
  • Capital increase, €135.000.000
  • Bank account, Deutsche Bank
  • Capital, €150.676.353
02-12
State Gazette act Appointment: Geoffrey Pot (director)
Mandate compensation3 facts ▸
  • General meeting, 12-11-2020
  • Director appointment, Geoffrey Pot (director)
  • Mandate compensation, Geoffrey Pot
02-12
State Gazette act Resignation: Yves Legrand (director)
2 facts ▸
  • General meeting, 02-11-2020
  • Director resignation, Yves Legrand (director)
04-11
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 4 days late
23-07
State Gazette act Resignations & appointments
Share concentration1 fact ▸
  • Share concentration, concentration of shares, 15-06-2020
29-04
State Gazette act Restructuring
Merger · Accounting effect · Statutes amendment6 facts ▸
  • General meeting, 31-03-2020
  • Merger, absorption, opération assimilée à une fusion par absorption
  • Accounting effect, 01-04-2020
  • Statutes amendment
  • Capital, €15.676.353
  • Merger project, 29-01-2020, article 12:50 du Code des sociétés et associations
19-03
State Gazette act Resignations & appointments
Power of attorney2 facts ▸
  • Board meeting, 20-01-2020
  • Power of attorney, Yves Legrand
20-02
State Gazette act Restructuring
Merger · Accounting effect · Sole shareholder5 facts ▸
  • Merger, 29-01-2020
  • Accounting effect, 01-04-2020
  • Sole shareholder, ja
  • Dissolution, sans liquidation
  • Expected agm date, 01-04-2020
28-01
State Gazette act Assemblee Generale - Annee Comptable
Statutes amendment3 facts ▸
  • General meeting, 20-12-2019
  • Statutes amendment
  • Statutes amendment
2019
17-09
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 48 days late
24-07
State Gazette act Appointment: KPMG Réviseurs d'Entreprises, Société Coopérative à Responsabilité Limitée, Société Civil à forme Commerciale (statutory auditor)
Resignation: Deloitte Réviseurs d'Entreprises, Société Coopérative à Responsabilité Limitée, Société Civil à forme Commerciale (statutory auditor)3 facts ▸
  • General meeting, 20-06-2019
  • Auditor appointment, KPMG Réviseurs d'Entreprises, Société Coopérative à Responsabilité Limitée, Société Civil à forme Commerciale (statutory auditor)
  • Director resignation, Deloitte Réviseurs d'Entreprises, Société Coopérative à Responsabilité Limitée, Société Civil à forme Commerciale (statutory auditor)
2018
13-11
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 105 days late
2017
29-09
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 60 days late
29-05
State Gazette act Resignations: Emmanuel Felix (director) and Mario Ricard (director)
Appointments: Pierre Dorignaux (director) and Yves Legrand (director) · Mandate compensation12 facts ▸
  • Written resolution
  • Director resignation, Emmanuel Felix (director)
  • Director resignation, Mario Ricard (director)
  • Director appointment, Pierre Dorignaux (director)
  • Director appointment, Yves Legrand (director)
  • Mandate compensation, Pierre Dorignaux
  • Mandate compensation, Yves Legrand
  • Board composition, Ramon Sanchez Carbajal (director)
  • Board composition, Yves Legrand (director)
  • Board composition, Pierre Dorignaux (director)
  • Board composition, François Hupet (director)
  • Board composition, Valérie De Schutter (director)
09-05
State Gazette act Appointment: Deloitte Reviseurs d'Entreprises (statutory auditor)
Permanent representative: Julie Delforge · Resignation: PricewaterhouseCoopers Bedrijfsrevisoren/Révisseurs d'Entreprises SC SCRL (statutory auditor)4 facts ▸
  • General meeting
  • Auditor appointment, Deloitte Reviseurs d'Entreprises
  • Permanent representative, Julie Delforge
  • Director resignation, PricewaterhouseCoopers Bedrijfsrevisoren/Révisseurs d'Entreprises SC SCRL (statutory auditor)
29-03
State Gazette act Appointment: Deloitte Reviseurs d'Entreprises (statutory auditor)
Permanent representative: Julie Delforge · Resignation: PricewaterhouseCoopers Bedrijfsrevisoren/Réviseurs d'Entreprises SC SCRL (statutory auditor)4 facts ▸
  • General meeting
  • Auditor appointment, Deloitte Reviseurs d'Entreprises
  • Permanent representative, Julie Delforge
  • Director resignation, PricewaterhouseCoopers Bedrijfsrevisoren/Réviseurs d'Entreprises SC SCRL (statutory auditor)
2016
31-08
NBB filing Annual accounts filed
fiscal year 2015 · full schema · 31 days late
07-06
State Gazette act Appointments: Ramon Sanchez Carbajal, François Hupet and Valérie De Schutter
Mandate compensation12 facts ▸
  • General meeting, 25-04-2016
  • Director appointment, Ramon Sanchez Carbajal (director)
  • Director appointment, François Hupet (director)
  • Director appointment, Valérie De Schutter (director)
  • Mandate compensation, Ramon Sanchez Carbajal
  • Mandate compensation, François Hupet
  • Mandate compensation, Valérie De Schutter
  • Board composition, Emmanuel Felix (director)
  • Board composition, Mario Ricard (director)
  • Board composition, Ramon Sanchez Carbajal (director)
  • Board composition, François Hupet (director)
  • Board composition, Valérie De Schutter (director)
2015
16-07
State Gazette act Resignations: Erich Kollegger, Herman Jacobs and 2 others
Appointment: Mario Ricard (director) · Mandate compensation9 facts ▸
  • General meeting, 04-06-2015
  • Director resignation, Erich Kollegger (director)
  • Director resignation, Herman Jacobs (director)
  • Director resignation, Andrea Borrell Vila (director)
  • Director resignation, Philippe Lodomez (director)
  • Director appointment, Mario Ricard (director)
  • Mandate compensation, Mario Ricard
  • Board composition, Emmanuel Felix (director)
  • Board composition, Mario Ricard (director)
06-07
State Gazette act Resignations & appointments · Restructuring
Demerger · Accounting effect · Capital increase5 facts ▸
  • General meeting, 30-04-2015
  • Demerger, 23h59, scission partielle
  • Accounting effect, 01-01-2015
  • Capital increase, €6.428.558
  • Capital, €15.676.353
08-05
State Gazette act Resignations & appointments
Power of attorney · Mandate term · Mandate start15 facts ▸
  • Power of attorney, Marjorie Halleux
  • Power of attorney, Natalie Goffin
  • Power of attorney, Tineke Van Hooland
  • Power of attorney, Martine Debecker
  • Power of attorney, Filip Chavatte
  • Mandate term, 31-12-2015
  • Mandate term, 31-12-2015
  • Mandate term, 31-12-2015
  • Mandate term, 31-12-2015
  • Mandate term, 31-12-2015
  • Mandate start, 30-04-2015
  • Mandate start, 30-04-2015
  • +3 further facts in this act
10-04
State Gazette act Appointment: PricewaterhouseCoopers Bedrijfsrevisoren/ Réviseurs d'Entreprises (statutory auditor)
2 facts ▸
  • General meeting, 09-03-2015
  • Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren/ Réviseurs d'Entreprises (statutory auditor)
12-03
State Gazette act Restructuring
Demerger · Capital increase · Capital decrease6 facts ▸
  • Demerger, Transfert des Activités Baxalta de la Société Transférante (Baxter SA) à la Société Scindée (Baxalta Belgium Manufacturing SA)
  • Capital increase, €15.614.853
  • Capital decrease, €15.614.853
  • Share issue, nominatives sans valeur nominale, 6428558
  • Accounting effect, 01-01-2015
  • Net-asset statement, 31-12-2014
2014
08-10
State Gazette act Incorporation
Appointments: Erich KOLLEGGER, Herman JACOBS and 3 others · Founding capital · Bank account18 facts ▸
  • Incorporation, 06-10-2014
  • Founding capital, €61.500
  • Bank account, Compte spécial ouvert auprès de Deutsche Bank AG
  • Founder, BAXTER NETHERLANDS HOLDING B.V.
  • Director appointment, Erich KOLLEGGER (director)
  • Director appointment, Herman JACOBS (director)
  • Director appointment, Emmanuel FELIX (director)
  • Director appointment, Andrea BORRELL VILA (director)
  • Director appointment, Philippe LODOMEZ (director)
  • Mandate compensation, Erich KOLLEGGER
  • Mandate compensation, Herman JACOBS
  • Mandate compensation, Emmanuel FELIX
  • +6 further facts in this act
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
31 of 31 acts read

Directors · office · real estate

Directors
4 directors, no change since 2026
Thierry PESTIAUX
Director · since 01-10-2025
Current
Indrajana Moeljadi
Director · since 07-10-2021
Current
François Hupet
Director · since 25-04-2016
Current
Valérie De Schutter
Director · since 25-04-2016
Current
19-02-2026 Patricia Denegri: Resigned as Director
01-10-2025 Thierry PESTIAUX: Appointed as Director
30-09-2025 Geoffrey POT: Resigned as Director
24-04-2022 François Hupet: Mandate renewed as Director
24-04-2022 Valérie De Schutter: Mandate renewed as Director
Full history in the Timeline (28 changes) →
Location & real-estate footprint
Registered office, Lessines · 1 establishment unit since 2014
seat establishment The establishment unit on the map
Ground area
9.3 ha
Building footprint
4.0 ha
Volume, LiDAR
68,672 m³
Parcel 55023C0872/00Y000, Wallonia · tallest building 15.5 m. Linked by address, not a title deed.
1 establishment unit
Baxalta Belgium Manufacturing
Boulevard René Branquart(L) 80, 7860 LessinesManufacture of basic pharmaceutical products and pharmaceutical preparations
since 20142.237.650.141
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
55023C0872/00Y000 Wallonia 9.3 ha 1 · 4.0 ha 15.5 m
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
KPMG Réviseurs d'EntreprisesCurrent
Auditor · represented by Axel JORION
21-10-2022 → present
Show 4 earlier auditors
Deloitte Réviseurs d'Entreprises
Auditor · represented by Julie Delforge
succeeded by KPMG Réviseurs d'Entreprises, Société Coopérative à Responsabilité Limitée, Société Civil à forme Commerciale in 2019
16-03-2017 → 20-06-2019
Deloitte Réviseurs d'Entreprises, Société Coopérative à Responsabilité Limitée, Société Civil à forme Commerciale
Statutory auditor
- → 20-06-2019
KPMG Réviseurs d'Entreprises, Société Coopérative à Responsabilité Limitée, Société Civil à forme Commerciale
Statutory auditor · represented by Axel Jorion
succeeded by KPMG Réviseurs d'Entreprises in 2022
20-06-2019 → 21-10-2022
PricewaterhouseCoopers Bedrijfsrevisoren/ Réviseurs d'Entreprises
Statutory auditor
succeeded by Deloitte Réviseurs d'Entreprises in 2017
09-03-2015 → 16-03-2017

Articles of association

Purpose
D'importer, d'exporter, d'acheter, de vendre, d'accorder des licences, de commercialiser, de distribuer, de fabriquer, de préparer et de conditionner en son nom et pour son compte…
Full purpose

D'importer, d'exporter, d'acheter, de vendre, d'accorder des licences, de commercialiser, de distribuer, de fabriquer, de préparer et de conditionner en son nom et pour son compte, ou en tant que représentant commercial ou commissionnaire, des produits pharmaceutiques, des dispositifs médicaux et des produits et services y relatifs, des produits, spécialités, articles et accessoires à usage pharmaceutique, thérapeutique, diététique, chirurgical, des instruments chirurgicaux, des produits chimiques, des articles d'hygiène, de parfumerie et droguerie, ainsi que d'accomplir des études, des essais, des recherches et des analyses qui s'y rapportent; de servir en tant que société "holding" pour les entités qui importent, exportent, achètent, vendent, octroient des licences, commercialisent, distribuent et conservent des produits pharmaceutiques, des dispositifs médicaux et des produits et services y relatifs: d'incorporer, de participer à, de conduire l'activité ou de prendre tout autre intérêt financier dans d'autres sociétés ou entreprises; de fournír des services administratifs, techniques, financiers, économiques, de consultance ou de gestion à d'autres sociétés ou entreprises; d'acquérir, de disposer, de gérer et d'utiliser des biens immeubles et meubles, en ce compris des brevets, marques, licences, permis et autres droits de propriété industrielle; de fournir des services de consultance et de gestion (intérimaire); d'accomplir tout acte industriel, commercial ou financier qui touche, directement ou indirectement, à son objet social; d'emprunter et/ou de prêter de l'argent et de fournir des suretés ou garanties ou toutes autres garanties d'exécution, conjointement et séparément dans l'intérêt d'autres, étant entendu que la société n'accomplira aucune activité qui est soumise à des dispositions légales ou réglementaires applicables aux institutions financières ou de crédit; et de fournir et d'accomplir toute autre activité qui est directement et indirectement liée aux objets précités, et ce au sens le plus large.

Structure & network

Connections & network

7 connected companies

Acquisitions and mergers

2 transactions
BE 0507.659.891merger by absorption · State Gazette act of 29-04-2020 (2 acts) · effective 01-04-2020
Received in a demerger part of:BAXTER
BE 0403.093.693partial demerger · State Gazette act of 06-07-2015 (4 acts) · effective 30-04-2015

Capital and shareholders

Shareholders according to the acts
At incorporation act of 08-10-2014 ↗

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 16-07-2026 Capital increase of 130,000,000 EUR · to 331,661,166.10 EUR · 1 new share · in cash
  2. 19-12-2024 Capital increase of 23.36 EUR · to 201,661,166.10 EUR · 1 new share
  3. 28-03-2022 Capital increase of 50,984,789.74 EUR · to 201,661,142.74 EUR · 2,182,505 new shares
  4. 15-12-2020 Capital increase of 135,000,000 EUR · to 150,676,353 EUR · 15,292 new shares · in cash
  5. 29-04-2020 Capital stated in the act · 15,676,353 EUR · 6,434,708 shares
  6. 06-07-2015 Capital increase of 6,428,558 EUR · to 15,676,353 EUR · 6,428,558 new shares
  7. 12-03-2015 Capital increase of 15,614,853 EUR · to 15,676,353 EUR · 6,428,558 new shares
  8. 08-10-2014 Incorporation · 61,500 EUR · 6,150 shares

Public money · subsidies and aid

Federal government

2023 to 2024 · 2 entries · 1,167,244 EUR in total
Year Department Transactions Amount
2024 FOD Economie 1 455,271 EUR
2023 FOD Economie 1 711,973 EUR
Budget allocations
Subsidies voor de verbetering van telecommunicatieconnectiviteit
2 entries · 1,167,244 EUR

Recognitions · licences · registrations

Food safety, FASFC

1 site
Lessines2.237.650.141
1 permission
Toelating · Andere grootkeuken (bereiding - distributie maaltijden) · since 05-12-2018

Legal Entity Identifier

549300KKK5Z3FKJ26S52
live in the LEI register

Similar companies · same sector, comparable size

Of 148 companies in sector 21100 we hold annual accounts for 108. 5 are within a factor 10 of this equity. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded06-10-2014
Fiscal year end31-03
Activities, NACEBEL 2025
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations

Scores and ratios are computed by Checked and are not a credit decision.